Metraipolis › archive › dc_19e56ccb10f7

Serum albumin-to-creatinine ratio as a novel and cost-effective biomarker for silent cerebral infarction: a retrospective cohort study — Europe PMC PMID:40917659

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40917659
DOI
10.3389/fneur.2025.1633402
License (as archived)
solo-consultazione
Archived
2026-11-10T11:00:04.548Z
SHA-256 of the archived text
e94ee04931d30fe42c1ef125217caa3ee61a8ea07c060dc21fc8d5da75cc0c2b
Stable URL of this page
https://metraipolis.com/documento/dc_19e56ccb10f7

How to cite

Serum albumin-to-creatinine ratio as a novel and cost-effective biomarker for silent cerebral infarction: a retrospective cohort study — Europe PMC PMID:40917659 — Europe PMC (en), https://europepmc.org/article/MED/40917659 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_19e56ccb10f7 (Metraipolis archive dc_19e56ccb10f7, sha256 e94ee04931d30fe42c1ef125217caa3ee61a8ea07c060dc21fc8d5da75cc0c2b)
BibTeX
@misc{dc19e56ccb10f7,
  title = {Serum albumin-to-creatinine ratio as a novel and cost-effective biomarker for silent cerebral infarction: a retrospective cohort study — Europe PMC PMID:40917659},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40917659},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_19e56ccb10f7; sha256 e94ee04931d30fe42c1ef125217caa3ee61a8ea07c060dc21fc8d5da75cc0c2b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40917659. Agents can read the archived copy with the MCP tool read_document.